Kymera Therapeutics · 8 hours ago
Associate Scientist or Scientist, Immunology
Greater Boston
Full-time
Onsite
Mid, Senior Level
$85K/yr - $150K/yrKymera Therapeutics is a clinical-stage biotechnology company pioneering targeted protein degradation to develop innovative medicines. The role involves developing and optimizing quantitative cell-based assays, characterizing lead molecules, and communicating research findings in project team meetings.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Develop and optimize quantitative cell-based assays to facilitate SAR and MOA studies for novel degraders using both immortalized and primary cells
Characterize lead molecules in vitro in human and animal primary immune and tissue cell types
Communicate research findings in cross-functional project team meetings
Review literature and conference proceedings to identify emerging technologies/assays and execute exploratory efforts for internal validation
Maintain good written records of laboratory procedures, expand and maintain cell banks, and uphold high standards of lab citizenship among peers
Qualification
Required
Relevant lab experience in immunology, cell biology, or related field
Extensive tissue culture experience with both immortalized and primary human cells
Deep knowledge in immunology, especially T-cell biology
Extensive hands-on experience with standard molecular and cell biology techniques: DNA construct design, transfection, viral transduction, genetic inhibition, ELISA, MSD, AlphaLISA, Western blot, RT-PCR, and flow cytometry, etc
Self-motivated, rigorous, efficient, and solution-oriented to deliver in a fast-paced environment with the ability to learn new areas as needed by project goals
Can independently develop/execute experiments and analyze/interpret results with minimal supervision while proactively seeking help and guidance as needed
Excellent organizational, verbal, and written communication skills and familiarity with electronic laboratory notebooks (ELN)
Benefits
Annual bonus
Equity participation
Comprehensive benefits
Company
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Founded in 2017
51-200 employees
H1B Sponsorship
Kymera Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (2)
2023 (4)
2022 (3)
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$1.96BKey Investors
Biotechnology Value FundAtlas Venture
2025-12-10Post Ipo Equity· $602M
2025-06-26Post Ipo Equity· $250.8M
2024-08-19Post Ipo Equity· $225M
Leadership Team
Nello Mainolfi
Founder, President and Chief Executive Officer
Jeremy Chadwick
Chief Operating Officer
Recent News
2026-01-16
2026-01-11
Company data provided by crunchbase